comparemela.com

Herve Fages News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Evoqua Water Technologies (NYSE:AQUA) Downgraded to Hold at Zacks Investment Research

Evoqua Water Technologies (NYSE:AQUA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports. According to Zacks, “Evoqua Water Technologies Corp. is a provider of mission critical water treatment solutions. The company offer services, systems and technologies to […]

Evoqua Water Technologies (NYSE:AQUA) Issues Quarterly Earnings Results

Evoqua Water Technologies (NYSE:AQUA – Get Rating) announced its quarterly earnings data on Tuesday. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02, Fidelity Earnings reports. Evoqua Water Technologies had a net margin of 3.36% and a return on equity of 13.60%. The business had […]

Evoqua Water Technologies Corp (NYSE:AQUA) Given Average Recommendation of Buy by Analysts

Shares of Evoqua Water Technologies Corp. (NYSE:AQUA – Get Rating) have received a consensus recommendation of “Buy” from the eight research firms that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price […]

Russell Investments Group Ltd Cuts Position in Evoqua Water Technologies Corp (NYSE:AQUA)

Russell Investments Group Ltd. trimmed its position in Evoqua Water Technologies Corp. (NYSE:AQUA – Get Rating) by 57.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,205 shares of the company’s stock after selling 34,851 shares during the quarter. […]

Evoqua Water Technologies (NYSE:AQUA) Rating Increased to Buy at Zacks Investment Research

Evoqua Water Technologies (NYSE:AQUA – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday, Zacks.com reports. The brokerage currently has a $53.00 price target on the stock. Zacks Investment Research‘s price objective points to a potential upside of 22.60% from the company’s […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.